News & Events

Seqplexing publishes its EOSAL-CNV technology in the book Methods and Molecular Biology

Compartir

Seqplexing has published a chapter in the Clinical Applications of Nucleic Acid Amplification section of the Methods and Molecular Biology book series.

Last April, Seqplexing had the pleasure of being part of volume 2621 of the Methods and Molecular Biology book series, specifically publishing the protocol "EOSAL-CNV for Easy and Rapid Detection of CNVs by Fragment Analysis" (https://doi.org/10.1007/978-1-0716-2950-5_13) in the Clinical Applications of Nucleic Acid Amplification block. This publication explains the protocol of the previously patented EOSAL-CNV technology published in Clinical Chemistry (2020 Feb 18). This technique is an alternative to MLPA for the study and characterization of CNVs.

Seqplexing

Seqplexing

Biotechnology Company focused on the development of genetic tests applicable in clinical and research. Sequencing Multiplex S.L. aims to simplify the methodology of genetic studies with products with a high biotechnological component and high added value. Our solutions simplify procedures by reducing the total time to obtain results, handwork and rationalizing spending